Complex containing mequitazine, a cyclodextrin and an interaction agent

A technology of mequitazine and complexes, applied in medical preparations containing active ingredients, medical preparations with non-active ingredients, drug combinations, etc., can solve the problems of low solubility and low bioavailability
CN101043908AInactive Publication Date: 2007-09-26PIERRE FABRE MEDICAMENT SAS
2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
PIERRE FABRE MEDICAMENT SAS
Publication Date
2007-09-26
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The invention concerns a complex comprising mequitazine, a cyclodextrin and an interactive agent characterized in that the solubilizing rate in water of the complexed mequitazine, measured for a mixture at 2g / l of mequitazine in water at 35 DEG C after being stirred for 15 minutes, in higher than 50 % at a pH of 9. The invention also concerns a method for preparing said complex and a pharmaceutical composition comprising same.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to complexes of mequitazine, cyclodextrin and an interacting agent which have a higher solubility than mequitazine alone. Background technique

[0002] Many pharmaceutically active substances suffer from low solubility in aqueous media and thus in biological media. This solubility can lead to lower bioavailability, necessitating increased dose administration. Such dose increases are not always without both side effects and also unfavorable from an economic point of view when considering the higher costs of the pharmaceutically active ingredients.

[0003] Mequitazine is an antihistamine used to treat allergies. The molecule of mequitazine is described in detail in patent FR 2 034 605 .

[0004] Mequitazine is usually administered by the oral route in various dosage forms such as syrups, tablets or gel caps.

[0005] As with many pharmaceutically active ingredients, the absorption of mequitazine administered by the oral...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More